COVID-19 Vaccination Linked to Small Increase in Menstrual Cycle Length
Data from the Natural Cycles app was analyzed for an association between COVID-19 vaccination menstrual cycle changes.
Diagnosis & Disease Information
Efficacy, Safety of the Ad5-nCoV Vaccine for Protection Against COVID-19
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
FDA Shortens Booster Dose Interval for Moderna COVID-19 Vaccine
The Moderna booster dose is authorized for individuals 18 years of age and older.
CDC Recommends COVID-19 Vaccine Booster Dose for 12- to 15-Year-Olds
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommends the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine in individuals 12 to 15 years of age at least 5 months after completion of the primary series. The advisory panel’s recommendations follow a similar decision made by…
Moderna COVID-19 Vaccine Booster Ups Antibody Levels Against Omicron
The study was conducted at laboratories established by the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center at Duke University Medical Center.
Early Data Show Evusheld Retains Neutralizing Activity Against Omicron
The FDA study shows that the neutralizing potency of the antibody combination was within the range of neutralizing titers found in an individual previously infected with COVID-19.
Supplemental BLA Submitted for Pfizer-BioNTech COVID-19 Vaccine for 12- to 15-Year-Olds
The application is supported by data from a randomized, placebo-controlled phase 3 trial which included 2228 participants 12 to 15 years of age enrolled in the United States.
Contraindication Added to Janssen COVID-19 Vaccine Fact Sheet
Cases of TTS have been reported in both males and females.
Pfizer-BioNTech COVID-19 Booster Authorized for 16- and 17-Year-Olds
Individuals in this age group should only receive this vaccine as their booster.
Early Data Suggest Potential Benefit of Heterologous Boosting for COVID-19
The independent study conducted by Dan Barouch, MD, PhD, et al of Beth Israel Deaconess Medical Center included a subset of participants from the COV2008 study.
- Loading...
Loading...
Next post in News
Loading... 
Loading...